Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00220519 · ClinicalTrials.gov registry record · NA
Lactobacillus GG Supplementation During Pediatric Burn Injuries
A NA study, sponsored by Shriners Hospitals for Children.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT00220519 is a NA study that was terminated before completion, run by Shriners Hospitals for Children. The registered enrollment target is 3 participants.
The verdict
NCT00220519, a NA study, was terminated before completion, sponsored by Shriners Hospitals for Children.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Critical illness and the therapies that accompany it are associated with a disruption in the ecological equilibrium of the GI tract that can ultimately lead to infection. Lactobacillus GG, a probiotic, replenishes the healthy flora of the intestinal tract and may decrease the risk of diarrhea and infection during critical illness. However, little is known about the impact of probiotics following a burn injury and the mechanisms behind the proposed benefits. The hypothesis of this research is that Lactobacillus GG decreases the incidence of diarrhea and infection in burned children receiving antibiotic therapy. The specific aim of this research is to determine the impact of Lactobacillus GG on the incidence of diarrhea and infection among burned children (\>20% TBSA) receiving antibiotic therapy.
Interventions
- DRUG Lactobacillus GG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00220519
The ClinicalTrials.gov registry entry for NCT00220519 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shriners Hospitals for Children, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lactobacillus GG is the first listed.
NCT00220519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00220519 about?
NCT00220519 is a clinical study titled "Lactobacillus GG Supplementation During Pediatric Burn Injuries". Critical illness and the therapies that accompany it are associated with a disruption in the ecological equilibrium of the GI tract that can ultimately lead to infection. Lactobacillus GG, a probiotic, replenishes the healthy flora of the intestinal tract and may decrease the risk of diarrhea and in...
What is the current status of trial NCT00220519?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2004-10. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00220519?
The interventions under investigation include: Lactobacillus GG (DRUG).
Who is sponsoring clinical trial NCT00220519?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.